These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 893226

  • 1. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN, Fuchs PC, Gavan TL, Gerlach EH, Barry A, Thornsberry C.
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [Abstract] [Full Text] [Related]

  • 2. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.
    Jones RN, Fuchs PC, Gavan TL, Gerlach EH, Barry AL, Thornsberry C.
    Antimicrob Agents Chemother; 1977 Jul; 12(1):47-50. PubMed ID: 883818
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD.
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [Abstract] [Full Text] [Related]

  • 4. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N, Aswapokee P, Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [Abstract] [Full Text] [Related]

  • 6. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.
    Jones RN, Thornsberry C, Barry AL, Fuchs PC, Gavin TL, Gerlach EH.
    J Antibiot (Tokyo); 1977 Jul; 30(7):583-92. PubMed ID: 893227
    [Abstract] [Full Text] [Related]

  • 7. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
    Leitner F, Misiek M, Pursiano TA, Buck RE, Chisholm DR, DeRegis RG, Tsai YH, Price KE.
    Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
    [Abstract] [Full Text] [Related]

  • 8. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
    Jones RN, Fuchs PC, Barry AL, Gavan TL, Sommers HM, Gerlach EH.
    Antimicrob Agents Chemother; 1980 Apr; 17(4):743-9. PubMed ID: 6446879
    [Abstract] [Full Text] [Related]

  • 9. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL, Thornsberry C, Jones RN, Fuchs PC, Gavan TL, Gerlach EH.
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [Abstract] [Full Text] [Related]

  • 10. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II.
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [Abstract] [Full Text] [Related]

  • 11. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB.
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [Abstract] [Full Text] [Related]

  • 12. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS, LeBlanc BM, Bodey GP.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [Abstract] [Full Text] [Related]

  • 13. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN, Fuchs PC.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [Abstract] [Full Text] [Related]

  • 14. An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin.
    Hamilton-Miller JM, Kerry DW, Brumfitt W.
    J Antibiot (Tokyo); 1974 Jan; 27(1):42-8. PubMed ID: 4843049
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 7-(Alpha-(1-methyl-4-pyridinothio)-acetamido) cephalosporanic acid.
    Buck RE, Leitner F, Price KE.
    Antimicrob Agents Chemother; 1972 Jan; 1(1):67-72. PubMed ID: 4670430
    [Abstract] [Full Text] [Related]

  • 17. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982 Jan; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

  • 18. Antibacterial activity of five cephalosporins.
    Mutton KJ, Harkness JL.
    Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG, Midtvedt T, Dahl O.
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.